🇺🇸 FDA
Pipeline program

von Willebrand factor (Recombinant)

071301

Phase 3 mab completed

Quick answer

von Willebrand factor (Recombinant) for Von Willebrand Disease is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Von Willebrand Disease
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials